BlackRock Fund Advisors’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	$1K	Buy	8 +1	+14%	+$125	﹤0.01%	4202
2016 Q3	$1K	Buy	7 +1	+17%	+$143	﹤0.01%	4230
2016 Q2	$1K	Buy	+6	New	+$1K	﹤0.01%	4291